Wiebe DA - Search Results

1

Plasma lipoprotein changes in humans induced by beta-interferon.

Rosenzweig IB, Wiebe DA, Borden EC, Storer B, Shrago ES. Rosenzweig IB, et al. Among authors: wiebe da. Atherosclerosis. 1987 Oct;67(2-3):261-7. doi: 10.1016/0021-9150(87)90287-5. Atherosclerosis. 1987. PMID: 3079540 Clinical Trial.

2

Effects of interleukin-2 (IL-2) on human plasma lipid, lipoprotein, and C-reactive protein.

Rosenzweig IB, Wiebe DA, Hank JA, Albers JJ, Adolphson JL, Borden E, Shrago ES, Sondel PM. Rosenzweig IB, et al. Among authors: wiebe da. Biotherapy. 1990;2(3):193-8. doi: 10.1007/BF02173519. Biotherapy. 1990. PMID: 1698421 Clinical Trial.

3

Effects of recombinant interferon-alpha 2 treatment upon lipid concentrations and lipoprotein composition.

Massaro ER, Borden EC, Hawkins MJ, Wiebe DA, Shrago E. Massaro ER, et al. Among authors: wiebe da. J Interferon Res. 1986 Dec;6(6):655-62. doi: 10.1089/jir.1986.6.655. J Interferon Res. 1986. PMID: 3572087

4

Lipid testing for the year 2000 and beyond.

Wiebe DA. Wiebe DA. Atherosclerosis. 1994 Aug;108 Suppl:S181-9. doi: 10.1016/0021-9150(94)90163-5. Atherosclerosis. 1994. PMID: 7802724

5

Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer.

Love RR, Newcomb PA, Wiebe DA, Surawicz TS, Jordan VC, Carbone PP, DeMets DL. Love RR, et al. Among authors: wiebe da. J Natl Cancer Inst. 1990 Aug 15;82(16):1327-32. doi: 10.1093/jnci/82.16.1327. J Natl Cancer Inst. 1990. PMID: 2199681 Clinical Trial.

6

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women.

Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, Jordan VC, Feyzi J, DeMets DL. Love RR, et al. Among authors: wiebe da. Ann Intern Med. 1991 Dec 1;115(11):860-4. doi: 10.7326/0003-4819-115-11-860. Ann Intern Med. 1991. PMID: 1952472 Clinical Trial.

7

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.

Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, Sosman JM. Stein JH, et al. Among authors: wiebe da. Circulation. 2001 Jul 17;104(3):257-62. doi: 10.1161/01.cir.104.3.257. Circulation. 2001. PMID: 11457741 Clinical Trial.

8

Postprandial lipoprotein changes in patients taking antiretroviral therapy for HIV infection.

Stein JH, Merwood MA, Bellehumeur JB, McBride PE, Wiebe DA, Sosman JM. Stein JH, et al. Among authors: wiebe da. Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):399-405. doi: 10.1161/01.ATV.0000152233.80082.9c. Epub 2004 Dec 2. Arterioscler Thromb Vasc Biol. 2005. PMID: 15576636

9

Comparison of NCEP performance specifications for triglycerides, HDL-, and LDL-cholesterol with operating specifications based on NCEP clinical and analytical goals.

Fallest-Strobl PC, Olafsdottir E, Wiebe DA, Westgard JO. Fallest-Strobl PC, et al. Among authors: wiebe da. Clin Chem. 1997 Nov;43(11):2164-8. Clin Chem. 1997. PMID: 9365403

10

Inaccuracy of lipid measurements with the portable Cholestech L.D.X analyzer in patients with hypercholesterolemia.

Stein JH, Carlsson CM, Papcke-Benson K, Einerson JA, McBride PE, Wiebe DA. Stein JH, et al. Among authors: wiebe da. Clin Chem. 2002 Feb;48(2):284-90. Clin Chem. 2002. PMID: 11805009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters